All Stories

  1. Percutaneous drainage of a fluid-containing emphysematous bulla
  2. Implementing rapid diagnostics for COVID-19
  3. Reply to Wilson: Improving Lung Cancer Screening Uptake
  4. Lung Screen Uptake Trial: results from a single lung cancer screening round
  5. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort
  6. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials
  7. Evaluation of cardiovascular risk in a lung cancer screening cohort
  8. Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial
  9. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
  10. Advances in pulmonary and pleural malignant disorders
  11. Does Dose Matter?
  12. Increasing radiology capacity within the lung cancer pathway: centralised work-based support for trainee chest X-ray reporting radiographers
  13. Immediate reporting of chest X-rays referred from general practice by reporting radiographers: a single centre feasibility study
  14. Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK
  15. Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK
  16. Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial
  17. Outcomes of 7 years of an integrated COPD service
  18. A gynaecological cause of spontaneous haemopneumothorax
  19. E-cigarettes and smoking cessation
  20. Transcriptional Profiling of Endobronchial Ultrasound-Guided Lymph Node Samples Aids Diagnosis of Mediastinal Lymphadenopathy
  21. A cough that doesn't fit the mould
  22. P2X3 receptor antagonist in chronic cough
  23. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs)
  24. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial
  25. A response to the LENT score
  26. Bronchial thermoplasty for asthma: evidence is lacking
  27. Children must be protected from the tobacco industry's marketing tactics
  28. Gabapentin for refractory chronic cough
  29. Transient hyperammonaemia in a patient with confusion: challenges with the differential diagnosis
  30. Granulomatous mediastinal adenopathy: can endoscopic ultrasound-guided fine-needle aspiration differentiate between tuberculosis and sarcoidosis?
  31. Generalised lymphadenopathy as the first manifestation of lupus nephritis
  32. Introduction: Medical Education
  33. Improving mucociliary clearance in chronic obstructive pulmonary disease
  34. Sleep Apnea and Heart Disease
  35. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD
  36. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation
  37. Roflumilast for chronic obstructive pulmonary disease
  38. Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
  39. Histone Deacetylase Activity and COPD
  40. Peak flow may be useful in screening for COPD in the absence of spirometry
  41. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
  42. Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease
  43. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
  44. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease
  45. Penetrating neck injury: case report and evaluation of management
  46. Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
  47. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
  48. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels
  49. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease